Pulmonary Metastases Exhibit Epigenetic Clonality: Implications for Precision Cancer Therapy

Pulmonary metastases exhibit patient-specific epigenetic clonality, which may be exploited for precision therapies targeting aberrant CT or TS gene expression. PRC-2 may be a shared target for epigenetic therapy of pulmonary metastases.